Jeffrey Blizard - 30 Sep 2026 Form 4 Insider Report for SANUWAVE Health, Inc. (SNWV)

Reporting relationship
Director
Issuer ticker
SNWV
Reported as of
30 Sep 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Oct 2026, 17:02:42 UTC
Prior SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Griffin D. Foster, Attorney-in-Fact for Jeffrey Blizard
Filing notes and source

Key filing fact

Jeffrey Blizard filed Form 4 for SANUWAVE Health, Inc. (SNWV) on 02 Oct 2026.

Key facts

  • This page summarizes Jeffrey Blizard's Form 4 filing for SANUWAVE Health, Inc. (SNWV).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 02 Oct 2026, 17:02.

Change

  • Previous filing in this sequence was filed on 02 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002012926 Primary reporting owner

Blizard Jeffrey

Relationship
Director
Address
9600 W. 76TH STREET, SUITE 118, EDEN PRAIRIE
Signature
/s/ Griffin D. Foster, Attorney-in-Fact for Jeffrey Blizard
Signature date
02 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNWV transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+11,286
Change %
Price
$0.000000*
Shares after
11,286
Date
30 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,286
Exercise price
$4.71
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options were fully vested at the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .